Related by context. All words. (Click for frequent words.) 82 Breast Cancer Symposium 79 AACR San Antonio 76 Breast Cancer Symposium SABCS 74 #rd Annual CTRC 73 ASH Annual Meeting 73 Genitourinary Cancers Symposium 73 EORTC NCI 72 AACR #st Annual Meeting 72 Annual Scientific Sessions 71 Gastrointestinal Cancers Symposium 71 AUA Annual Meeting 70 Digestive Diseases Week 70 Symposium SABCS 70 Rheumatology ACR Annual 70 Pediatric Academic Societies PAS 69 SABCS 69 Endocrine Society #nd 69 Hematology ASH Annual Meeting 69 Therapeutics TCT scientific 69 Digestive Disease Week DDW 69 Society CTOS 68 ASCO GI 68 AHA Scientific Sessions 68 Connective Tissue Oncology 68 nd Annual Meeting 68 AACR #nd Annual Meeting 68 #nd Annual Meeting 67 #st Annual Meeting 67 ICAAC IDSA 67 EORTC NCI AACR Symposium 67 annual Transcatheter Cardiovascular 67 Therapeutics TCT 67 ADA Scientific Sessions 67 ISPOR 67 ECTRIMS 67 Digestive Disease Week 66 Advanced Neuroendocrine Tumors 66 Biological Therapy 66 Arteriosclerosis Thrombosis 66 ASCO GU 66 America HFSA 66 Clinical Oncology Annual Meeting 66 AACR IASLC Joint 66 AACR Frontiers 66 Prostate Cancer Symposium 66 ASCO Genitourinary Cancers Symposium 66 Endocrine Society ENDO 66 European CanCer Organisation ECCO 66 Transcatheter Cardiovascular Therapeutics TCT 66 Chicago Multidisciplinary Symposium 66 AACR NCI EORTC 66 CTRC AACR 66 Hematology Annual Meeting 65 Endocrine Society #st 65 Annual Transcatheter Cardiovascular 65 ICAAC 65 Endocrine Society Annual Meeting 65 UEGW 65 #nd EORTC NCI 65 Related Disorders ICAD 65 Gastrointestinal Cancer 64 Rheumatology Annual 64 st Annual Meeting 64 Pediatric Academic Societies 64 Hematology Meeting 64 ASCO Annual Meeting 64 Cancers Symposium 64 Opportunistic Infections CROI 64 San Antonio Breast Cancer 64 #th Interscience Conference 64 Oncology ASTRO 64 #th Annual Interscience 64 Gastroenterology ACG Annual 64 Vascular Annual Meeting 64 ASCO Breast Cancer 64 Annual Interscience Conference 64 Annual ICAAC 64 Late Breaker 64 IASLC 64 VEITHsymposium 64 GTCbio 63 PreCISe 63 ASTRO Annual Meeting 63 Therapeutic Radiation 63 SPIRIT IV 63 Hematology ASH 63 Prostate AdenoCarcinoma Treatment 63 Phase III ADT 63 Fifth Decennial International 63 Molecular Origins 63 Medical Oncology ESMO 63 Mineral Research ASBMR 63 SUCCEED trial 63 LUX Lung 62 Liver EASL 62 BIOCOM Investor Conference 62 AAN Annual Meeting 62 ABRF 62 AACR Annual Meeting 62 ASBMR 62 ExTRACT TIMI 62 Clinical Trials Update 62 Neurology AAN 62 DDW ® 62 AAAAI Annual Meeting 62 Transcatheter Cardiovascular Therapeutics 62 AAPS Annual Meeting 62 ACR ARHP Annual 62 BCIRG 62 Pediatric Academic Society 62 CROI 62 HORIZONS AMI 62 IMPROVE HF 62 registrational Phase 62 Screening Trial 62 AACR Meeting 62 AASLD Meeting 62 Clinical Oncology ASCO Annual 62 bazedoxifene conjugated estrogens 62 ® DDW 62 AAO HNSF Annual Meeting 62 evaluating tivozanib 62 ECCMID 61 Gynecologic Cancer Society 61 AASLD 61 Molecular Targets 61 RECORD1 61 EORTC NCI AACR 61 PROSTVAC TM 61 ACR ARHP 61 Randomized Phase 61 AVADO 61 Interventions SCAI 61 Cell Biology ASCB 61 ECCO ESMO 61 League Against Rheumatism 61 Infectious Diseases ECCMID 61 Radiation Oncology ASTRO 61 CLEO QELS 61 PROactive Study 61 HFSA Annual 61 Outpatient Setting 61 AVERROES 61 Liver Diseases AASLD 61 Nephrology Renal Week 61 Phase Ib II 61 Neoplasia 60 phase IIb study 60 NASDAQ CYTK announced 60 Clinical Oncology Gastrointestinal Cancers 60 ICON7 60 metastatic castration resistant 60 International Papillomavirus 60 TG MV 60 STRIDE PD 60 HORIZONS AMI trial 60 EULAR Annual 60 American Roentgen Ray 60 Scientific Sessions 60 Microbiology ASM 60 SCAI Annual 60 Cambridge Healthtech Institute 60 randomized controlled Phase 60 journal Antimicrobial Agents 60 Opportunistic Infections 60 abstracts summarizing 60 ONTARGET 60 ORAL Sync 60 ENDEAVOR IV 60 Human Genetics ASHG 60 INSPIRE Trial Phase III 60 Breaking Clinical Trials 60 Ovarian PLCO Cancer 60 Group RTOG 60 Therapeutic Radiation Oncology 60 Immunology Annual Meeting 60 Canaccord Adams Hepatitis C 60 prospective multicentre 60 MEND CABG 60 Maternal Fetal Medicine SMFM 60 Neurology Annual Meeting 60 AACR 60 Lung Cancer IASLC 60 Gynecologic Oncology Group 60 Medicine ISMRM 60 Cardiostim 60 GASTRO 60 Gastroenterology ACG 60 Clinical Endocrinologists AACE 60 Hypertension ASH 59 International Myeloma Workshop 59 Therapeutic Radiology 59 Keystone Symposia 59 Postgraduate Course 59 randomized Phase III 59 EuroPCR 59 Scientific Session 59 ESTRO 59 Cancer iSBTc 59 PRNewswire FirstCall Tercica 59 Preclinical Study 59 Cardiovascular Disease Epidemiology 59 Interventional Radiology SIR 59 Inc. Nasdaq OPTR 59 multicenter Phase 59 Dr. Gulfo 59 teriflunomide 59 EORTC 59 Prostate Lung Colorectal 59 AABB Annual Meeting 59 CARE HF 59 Pharmaceutical Scientists AAPS 59 Hormone Refractory Prostate Cancer 59 Printable slides 59 Alzheimer Disease ICAD 59 Malignant Lymphoma 59 ongoing Phase 1b 59 Sangamo BioSciences Announces 59 EMBLEM TM 59 transthyretin TTR mediated amyloidosis 59 LungSign TM 59 ABCSG 59 sorafenib tablets 59 CRLX# 59 USpella 59 Poster Discussion 59 BRIM2 59 oral FTY# 59 Inc. Nasdaq AMLN 59 Multilateral Initiative 59 American Psychosomatic Society 59 Carotid Revascularization Endarterectomy vs. 59 FOLOTYN ® 59 number NCT# ClinicalTrials.gov 59 Cancer Therapeutic 59 Phase Ib study 59 Phase #b/#a clinical 59 Molecular Markers 59 GVAX ® 59 PERSEUS clinical program 59 PSMA ADC 59 multicenter Phase III 59 Recurrent Chest Wall 59 pharmacokinetic PK 59 alvespimycin 59 AIR2 Trial 59 Neck Surgery Foundation 59 RCW Breast Cancer 59 Gene Therapy ASGT 59 evaluating mipomersen 59 placebo controlled Phase III 59 iSBTc 59 SAEM Annual Meeting 59 EFNS 59 Xelox 59 EUROGIN 59 Combination REOLYSIN R 58 Breast Surgeons 58 Heart Failure Therapies 58 Molecular Medicine Tri 58 novel VDA molecule 58 BRIM3 58 dose escalation clinical 58 ALN VSP Phase 58 Nordic ACTI 58 Phase #/#a trial 58 NCCTG N# 58 Hsp# Inhibitor 58 Gynecological Cancer 58 CYT# potent vascular disrupting 58 ongoing Phase IIIb 58 Retroviruses 58 BIO InvestorForum 58 pelvic malignancies 58 ESMO 58 PROTECT II 58 ARVO 58 Prospective Multicenter 58 Aggressive Reduction 58 LSE ASM 58 By JENNIFER LEARN 58 ASMS Conference 58 NSABP 58 kidney urologic 58 multicenter phase 58 CR# vcMMAE 58 Endovascular Therapy ISET 58 Pirfenidone 58 PERSEUS 58 PROTECT AF 58 PCI ExTRACT TIMI 58 IL# PE#QQR 58 Molecular Cancer 58 Neurological Surgeons AANS 58 Diabetes EASD 58 ELACYT 58 ADVANCE PD 58 Clinical Trial Results 58 NO# [002] 58 Xcytrin R 58 ThermoDox ® clinical 58 Endocrine Practice 58 YONDELIS 58 Hematology ASH Meeting 58 Antithrombotic 58 CTI Nasdaq 58 CLL8 58 Experimental Biology EB 58 HCV NS5B polymerase 58 PRNewswire FirstCall Nektar Therapeutics 58 ASGT 58 Phase III AFFIRM 58 Digital Mammographic Imaging 58 neratinib 58 Phase #/#a 58 delafloxacin 58 Cystic Fibrosis Conference NACFC 58 #th Annual Retrovirus 58 ACC.# 58 Antimicrobial Agents 58 Randomized Phase III 58 Chemotherapy ICAAC 58 comparing alemtuzumab 58 Pooled Analysis 58 CAMMS# 58 Randomized Double blind 58 Antibody Therapeutics 58 HCV SPRINT 58 Selective Cardiac Myosin 58 EXPLORE Xa 58 BOLDER II 58 Gastrointestinal Oncology 58 Scientific Meeting 58 Refractive Surgery ASCRS 58 Oral Presentations 58 EVEREST II 58 Phase 1b clinical trials 58 Cancer Incidence Mortality 58 Clinical Oncologists 58 Chest Physicians CHEST 58 IMPACT DCM 58 randomized discontinuation trial 58 malignant mesothelioma Alfacell 58 radezolid 58 phase Ib 58 Stem Cell Research ISSCR 58 pertuzumab 58 Tor Bjerkedal report 58 American Thoracic Society 58 SoftScan R 58 Poster Presentation 57 CombAT 57 ANN INTERN MED 57 RADIANT 57 Folfox 57 NEVO RES 57 APPRAISE 57 SPIRIT FIRST 57 GLOBE NEWSWIRE Cyclacel Pharmaceuticals 57 Tanespimycin 57 Vascular Biology ATVB 57 Environ Health Perspect 57 & Immunology AAAAI 57 ACRIN 57 PROVENGE sipuleucel T 57 assessing T DM1 57 Heart Failure Society 57 prospective multicenter 57 PROLARIS 57 Neuro Oncology SNO 57 Aplidin R 57 Pre RELAX AHF 57 oral Xeloda 57 Platelet Inhibition 57 preclinical efficacy 57 Aflibercept 57 Phase 2b Clinical Trial 57 Azedra 57 Drugs Affecting Lipid 57 fidaxomicin Phase 3 57 Phase Ib clinical 57 AACR symposium 57 EXPAREL ™ 57 recurrent glioma 57 journal Arteriosclerosis Thrombosis 57 ASCO Gastrointestinal Cancers Symposium 57 HER2 positive metastatic breast 57 Randomized Double Blind 57 Clinical Antipsychotic Trials 57 Inc. NASDAQ HEPH 57 sipuleucel T 57 RIO Lipids 57 Acute Heart Failure 57 II Clinical Trial 57 Active Biotech NASDAQ OMX 57 Kahalalide F 57 Metastatic Melanoma 57 multicenter trials 57 RE LY 57 pharmacokinetic PK study 57 farletuzumab 57 Biomacromolecules 57 CBLC# 57 AACR EORTC NCI 57 Evaluation WISE 57 Menopause Society NAMS 57 th Interscience Conference 57 Outcomes Research ISPOR 57 AAG geldanamycin analog 57 BARI 2D 57 Pivotal Phase 57 Phase III ALLEGRO 57 plus Copegus R 57 Breaking Clinical Trial 57 Cardiovascular Interventions 57 Anticancer Drugs 57 Intervention Trial GAIT 57 ERA EDTA 57 Ophthalmology ARVO 57 BiTE antibody MT# 57 iPrEx 57 Prospective Randomized 57 DASISION 57 Double Blind Placebo 57 journal Oncogene 57 Proc Am Soc 57 Antiepileptic Drugs 57 NASDAQ SLXP today 57 Vaccine Immunology 57 Oral Fingolimod 57 ASA CSSA SSSA 57 EFORT Congress 57 multicenter Phase II 57 FDA Oncologic Drugs 57 EASL 57 phase IIa clinical 57 Cancer Immunotherapy 57 Celecoxib APC trial 57 standard chemotherapy regimen 57 ASCEND HF 57 See CLINICAL PHARMACOLOGY 57 CTAP# Capsules 57 CUSTOM III 57 Chemotherapy ICAAC Infectious Diseases 57 riociguat 57 lucinactant 57 arzoxifene 57 Randomized Phase II 57 trastuzumab DM1 T DM1 56 Relapsed Multiple Myeloma 56 viral kinetic 56 EchoCRT 56 CURRENT OASIS 7 56 NSABP B 56 Cloretazine ® 56 NCCN guidelines 56 ROCKET AF 56 Brentuximab Vedotin SGN 56 SWOG 56 Archived webcasts 56 Interscience Conference 56 Systemic Sclerosis 56 HuMax EGFr 56 TORISEL TM 56 XL# SAR# 56 PRE SURGE 56 Midatlantic Employers Association 56 EURONEXT SAN 56 FOLFOX6 chemotherapy regimen 56 Gynecological Cancers 56 KRAS variant 56 candidate CRLX# 56 Initiated Phase 56 MGd 56 ASN Renal Week 56 Elagolix 56 Malignant Mesothelioma 56 Intervention Effectiveness 56 discussed NuroPro Power3 56 ASCRS 56 Trial NLST 56 Liver Disease AASLD 56 Diabetic Macular Edema 56 Clinical Oncology ASCO 56 European Randomized Study 56 EMPOWER ™ 56 Mass Spectrometry ASMS 56 ToGA 56 ASGCT 56 & OTO EXPO 56 Pharmacoeconomics 56 Vandetanib 56 Multiethnic Study 56 Nephrol Dial Transplant 56 ENDEAVOR clinical 56 tanespimycin 56 Amy Abernethy 56 ISTH 56 evaluating REVLIMID 56 TAXUS ATLAS 56 tolerability pharmacokinetics 56 Oligonucleotide Therapeutics Society 56 Genta Incorporated OTCBB GETA 56 Ocrelizumab 56 CALGB 56 NSABP C 56 SAWC WHS 56 CT Colonography Trial 56 journal Gynecologic Oncology 56 Prednisone Against Refractory 56 PRNewswire FirstCall Genaera 56 multicenter placebo controlled 56 Zemplar Capsules 56 ELCAP 56 cetuximab Erbitux 56 Targeted Therapies 56 huC# DM4 56 Canaccord Genuity Musculoskeletal 56 REG2 56 Arch Surg 56 investigational immunotherapy 56 Safinamide 56 Phase III multicenter 56 olaparib 56 placebo controlled Phase 56 Immunology ACAAI 56 ASM Biodefense 56 Cardiovascular Horizons 56 fidaxomicin Phase 56 Bazedoxifene 56 vorinostat 56 Needham Biotechnology 56 Solid Tumors 56 Research IADR 56 depsipeptide 56 Planetary Science Conference 56 Retrovirus Conference 56 Tumor Microenvironment 56 Diabetic Macular Edema DME 56 ATVB 56 Phase 1b trial 56 TAXUS IV 56 Controlled Trial 56 HDL Mimetic Peptide 56 Cardiology ACC 56 Trandolapril 56 PLCO 56 Edge STudy 56 SoftScan ® 56 Cancer MASCC 56 ISHLT 56 BACcel ™ system 56 Inflammatory Arthritis 56 First Patient Enrolled 56 Epilepsy Society 56 phase IIb clinical 56 NCIC CTG 56 OPT CHF 56 preclinical pharmacokinetic 56 BiTE R 56 Biodetection Technologies 56 Association EHA 56 phase IIIb 56 placebo controlled clinical 56 Phase III placebo controlled 56 MOZOBIL 56 NEUVENGE 56 Solorel TM 56 oral prodrug 56 Phase 2a Study 56 ENDEAVOR III 56 journal Palaios 56 substudy 56 BioNumerik 56 Ann Oncol 56 undergoing elective percutaneous 56 Clinical Microbiology 56 TTF Therapy 56 HCV Protease Inhibitor 56 TRA 2P 56 rALLy trial 56 Canaccord Adams Musculoskeletal 56 Antiviral Research 56 Ranolazine 56 Nephrology ASN 56 relapsed MM 56 Urology EAU 56 FDA Endocrinologic 56 GITA Annual 56 Therapeutic Targets 56 Evaluation Program CTEP 56 National Surgical Adjuvant 55 ACS Chemical Biology 55 LymphoStat B 55 Telik Announces 55 Clinical Chemistry AACC 55 Therapeutic Approaches 55 ASCO 55 oral ridaforolimus 55 Dialysis Outcomes 55 Cell Transplant 55 ENDO 55 Cancer Epidemiol Biomarkers Prev 55 Gynecologic Oncologists 55 Plastic Surgeons ASPS Plastic 55 GRNCM1 55 TASKi2 55 fosbretabulin 55 Geochimica et Cosmochimica Acta 55 Perinatal Epidemiology 55 Quinamed 55 Bowel Project 55 SPIRIT III 55 NuroPro ® AD 55 Clinical Trial Data 55 RANK Ligand inhibitor 55 Transplant Surgeons ASTS 55 Hedgehog Pathway Inhibitor 55 developer Antisoma plc 55 pralatrexate injection folate analogue 55 Biennial Meeting 55 ALN TTR 55 Temsirolimus 55 REALITY Trial 55 Endoscopic Surgeons SAGES 55 ASCO abstract 55 Radiation Therapy Oncology 55 PROSTASCINT R 55 Gynecologic Oncologists SGO 55 Glucosamine Chondroitin Arthritis 55 Physiology Endocrinology 55 IMPACT IMmunotherapy 55 NCCN Clinical Practice 55 Hormone Receptor Positive 55 TEMSO 55 Cardiovascular Anesthesiologists 55 prospective observational studies 55 journal Hepatology 55 NCCTG 55 Focal Therapy 55 Room #AB [002] 55 Carfilzomib 55 Br J Cancer 55 NCVH 55 By DJ Abisalih 55 YOUR LOCAL ANIMAL SHELTER 55 Dendritic Cells 55 ovarian endometrial 55 RE LY trial 55 ACUITY trial 55 MERLIN TIMI 55 Inc. NASDAQ SPPI 55 rALLy clinical trial 55 RTOG 55 metaglidasen 55 Acute Myocardial Infarction 55 Val HeFT 55 GLOBE NEWSWIRE Pressure BioSciences 55 Inc. Nasdaq INFI 55 Therapeutic Advances 55 Phase 2a trial 55 orally inhaled migraine 55 Vascugel ® 55 ORAL Solo 55 resistant hormone refractory 55 OTO EXPO 55 Rheumatology Annual Meeting 55 Delcath Phase III 55 Human Proteome Organization 55 Long Awaited Reality 55 Gynecologic Investigation 55 enzastaurin 55 Completes Patient Enrollment 55 Inc. Nasdaq AVRX 55 p# biomarker 55 lexidronam injection 55 Deforolimus 55 Chronic Lymphocytic Leukemia CLL 55 metastatic hormone refractory 55 TACI Ig 55 Demonstrates Sustained 55 trial evaluating PRX# 55 AEG# 55 Abstract Accepted 55 Midyear Clinical Meeting 55 Clinical Outcomes Utilizing Revascularization 55 ILLUMINATE 55 ConclusionThis 55 journal Menopause 55 recurrent glioblastoma multiforme 55 ARVO Annual Meeting 55 oral deforolimus 55 KRN# 55 Multicenter Randomized 55 ORACLE MS 55 Sorafenib HCC Assessment 55 Phase Ib Clinical Trial 55 Multicenter Phase 55 www.asco.org 55 AVN# Phase 55 Biophysical Society 55 EULAR 55 BR.# 55 PRIMO CABG2 55 Annual BIO 55 EGS# 55 IRX 2 55 prospective multicenter study 55 Inc. NASDAQ NBIX 55 Circulation Cardiovascular Interventions 55 ECNP Congress 55 forodesine 55 Tumor Response 55 Preclinical Data 55 microsphere therapy 55 Presents Preclinical 55 Phase 2b RESTORE CLI 55 Colorectal Cancer CRC 55 Women Ischemia Syndrome 55 Nasdaq IDRA today 55 CALGB # [002] 55 Genitourinary Cancer 55 Electro Optics CLEO 55 CoFactor 55 PRECISE 55 interferon gamma 1b 55 ASMBS 55 Autoimmunity 55 HDL Selective Delipidation 55 Wisconsin Sleep Cohort 55 Pivotal Clinical Trial 55 Inc. Nasdaq ATHX 55 personalized cellular immunotherapy 55 ECNP 55 Annual CTRC AACR 55 prospective observational 55 Refractory Angina 55 Sipuleucel T 55 J Am Coll 55 PRNewswire FirstCall Genta Incorporated 55 Personalized Immunotherapy 55 Clin Chem 55 ALSYMPCA 55 Ophthalmic Drugs Advisory 55 astronomers physicists 55 HCV RESPOND 2 55 Female Urology 55 randomized metastatic breast 55 prospective observational cohort 55 Epeius Biotechnologies Corporation 55 Screening Trial DMIST 55 RNAi Therapeutic 55 PRNewswire FirstCall Kensey Nash 55 MelaFind R 55 Lysosomal Disease Network 55 YONDELIS R 55 NABTT 55 trastuzumab DM1 55 Network HVTN 55 PEG SN# 55 journal PLoS Pathogens 55 colleague Sana Inoue 55 Surgical Oncology SSO 55 vinca alkaloid 55 chromium supplementation 55 PIX# [002] 55 MERIT ES 55 Addex Pharmaceuticals SIX ADXN 55 KRAS gene mutations 55 Abstract P#.# 55 Dose Escalation 55 oral rivaroxaban 55 Curaxin CBLC# 55 blinded randomized placebo controlled 55 American Physiological Society 55 Lung Transplantation 54 Spine Arthroplasty Society 54 Ocular Pharmacology 54 Zenvia Phase III 54 worsening thrombocytopenia 54 Microalbuminuria 54 randomized multicenter trial 54 Asthma Intervention 54 PRNewswire FirstCall Amylin Pharmaceuticals 54 ARBITER 6 54 Medicine AAPM 54 Experimental Hematology 54 REVIVE Diabetes 54 GTCbio 3rd 54 Nasdaq SGMO announced 54 ACS Molecular Pharmaceutics 54 APEX PD 54 Hepatocellular Carcinoma 54 & Rheumatism journal 54 AAO HNSF 54 Seconds Count 54 cediranib 54 AAPM 54 GOUT 54 Pertuzumab 54 Targeted Anticancer Therapies 54 ganetespib 54 TIMI Study Group 54 EASD 54 Serious Infections 54 CIMZIA TM certolizumab pegol 54 CODiE Awards Gala 54 Phase III ThermoDox 54 multicenter randomized clinical 54 intravesical infusion therapy 54 multicenter prospective 54 Stenting Trial CREST 54 ixabepilone 54 haplotype map 54 stent DES 54 CAPRISA 54 OTCBB AOLS 54 coronary stent merged 54 DNA methylation markers 54 Respiratory Viral Infections 54 including eniluracil ADH 54 International Verapamil SR 54 ALS MND 54 European CanCer Organisation 54 Chemophase 54 EOquin TM 54 Metastatic Prostate Cancer 54 Am J Epidemiol 54 Cancer AACR NCI 54 Severe Sepsis 54 Diabet Med 54 papillary renal cell carcinoma 54 rivaroxaban Xarelto 54 seliciclib CYC# 54 Alocrest 54 Recurrent Breast Cancer 54 Neck Cancer 54 Nasdaq PCYC 54 Crit Rev 54 Truvada tablets 54 EMBO J. 54 Uterine Fibroid Embolization 54 #-# Full Text 54 Ann Rheum Dis 54 American Urological Association 54 Patient Registry 54 recurrent GBM 54 Am J Pathol 54 Phase III Clinical Trials 54 Applied Spectroscopy 54 PFO migraine 54 Advaxis Phase 54 Neurological Surgeons Annual Meeting 54 NASDAQ CXSP announced 54 practicing cardiovascular interventionalists 54 Int J Epidemiol 54 Phase III Clinical Trial 54 recurrent malignant glioma 54 Clinical Practice Guideline 54 Anticancer Research 54 undergone radical prostatectomy 54 deforolimus 54 Arch Neurol 54 PRESEPT 54 Podium Presentation 54 strapless organza pleated gown 54 Vulnerable Plaque 54 PEGylated interferon beta 1a 54 BioPharm America 54 Overactive Bladder OAB 54 Cardiology Scientific Sessions 54 OTCBB AOLS announced 54 Clinical Gastroenterology 54 HIF PHI 54 Cardiac Resynchronization 54 Daclizumab 54 R roscovitine 54 Phase 2b Trial 54 Semafore Pharmaceuticals 54 Nebulized Formoterol 54 oncolytic virus therapies 54 metastatic neuroendocrine tumors 54 RE LY ® 54 C# BioVentures Conference 54 Phase IIIb clinical 54 Chronic Heart Failure 54 scientific journal PNAS 54 Topline Results 54 ACCORD Eye 54 Bowel Project NSABP 54 prostate cancer mCRPC 54 Phase 2a clinical 54 Surgical Treatment 54 Relapsing Multiple Sclerosis 54 Photovoltaics Summit 54 entitled Synergistic 54 Advanced Melanoma 54 Inc. Nasdaq RDYN 54 antibody blinatumomab MT#/MEDI-# 54 Paroxysmal Nocturnal Hemoglobinuria PNH 54 CHEST 54 Liver Transplantation journal 54 REACH Registry 54 Cholesterol Levels SPARCL 54 article #.#/NEJMoa# 54 pediatric acute lymphoblastic 54 Developmental Therapeutics Immunotherapy 54 PRNewswire FirstCall AEterna Zentaris 54 J Clin Oncol 54 MEK Inhibitor 54 ENESTnd 54 Physical Therapy PTJ 54 Consortium ICGC 54 PRNewswire FirstCall Bionovo 54 Trial PCPT 54 Acute Ischemic Stroke 54 Peer Reviewed Journal 54 HQK 54 Gastrointestinal Endoscopy ASGE 54 Nicotine Vaccine 54 DMIST 54 Selective Cardiac Myosin Activator 54 LUMINATE 54 PRNewswire FirstCall ViroPharma Incorporated 54 multicenter clinical 54 ACOSOG Z# 54 surveys Herbenick 54 NASDAQ ABII 54 interventional vascular medicine 54 Biological Sciences AIBS 54 CHARISMA trial 54 galiximab 54 Diabetologia 54 Inc. Nasdaq SGMO 54 GENASIS 54 Clinical Oncology ASCO Gastrointestinal 54 Lancet Oncology journal 54 Updated DAILY 54 hormone refractory metastatic prostate 54 Inc. Nasdaq ULGX 54 Respiratory Society 54 GLOBE NEWSWIRE Integra LifeSciences 54 randomized controlled clinical 54 Syllego system 54 LibiGel ® 54 phase IIb trial 54 Thoracic Oncology 54 WHO TOOK 54 Haemostasis ISTH 54 #King Bong Paul 54 Prostate Disease 54 Metabolic Disorders 54 J Clin Endocrinol Metab 54 JNCI 54 INCB# [001] 54 & Analgesia retracted 54 Phase #b/#a 54 Nasdaq ONXX today 54 Carla Vecchiotti 54 Histopathologic 54 pain palliation 54 NeuroImage 54 ASTEROID 54 journal Resuscitation 54 MADIT CRT 54 Marine Mammal Protected Areas 54 Cardiac Allograft Rejection 54 Ixempra 54 International Neuropsychological Society 54 thetreatment 54 gastro intestinal inflammation 54 Partnership Attitude Tracking 54 EACTS 54 ® cetuximab 54 MYTHOS trial 54 PNP inhibitor 54 lorcaserin Phase 54 Prolongs Survival 54 Heart Failure Trial 54 Biotech Showcase 54 HYVET 54 J Natl Cancer Inst 54 PROSTVAC VF 54 AAAS Annual Meeting 54 ADVANCE ILLUMINATE 54 Cardiology ESC 54 CHAMPION PCI 54 confirmatory clinical 54 Nat Med 54 Stent Thrombosis 54 Metabolic Endocrinology 54 CEQ# 54 BioCentury Future Leaders 54 J Antimicrob Chemother 54 DAVANAT 54 TMC# C# 54 HUPO 54 Venereology EADV 53 Multi Ethnic Study